pubmed-article:19100620 | rdf:type | pubmed:Citation | lld:pubmed |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C0521451 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C0441889 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C1705165 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C0031164 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C1996904 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C0596235 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C1880497 | lld:lifeskim |
pubmed-article:19100620 | lifeskim:mentions | umls-concept:C2700061 | lld:lifeskim |
pubmed-article:19100620 | pubmed:issue | 3 | lld:pubmed |
pubmed-article:19100620 | pubmed:dateCreated | 2009-3-9 | lld:pubmed |
pubmed-article:19100620 | pubmed:abstractText | Mitochondrial Ca(2+) activates many processes, from mitochondrial metabolism to opening of the permeability transition pore (PTP) and apoptosis. However, there is considerable controversy regarding the free mitochondrial [Ca(2+)] ([Ca(2+)](M)) levels that can be attained during cell activation or even in mitochondrial preparations. Studies using fluorescent dyes (rhod-2 or similar), have reported that phosphate precipitation precludes [Ca(2+)](M) from increasing above 2-3 microM. Instead, using low-Ca(2+)-affinity aequorin probes, we have measured [Ca(2+)](M) values more than two orders of magnitude higher. We confirm here these values by making a direct in situ calibration of mitochondrial aequorin, and we show that a prolonged increase in [Ca(2+)](M) to levels of 0.5-1mM was actually observed at any phosphate concentration (0-10mM) during continuous perfusion of 3.5-100 microM Ca(2+)-buffers. In spite of this high and maintained (>10 min) [Ca(2+)](M), mitochondria retained functionality and the [Ca(2+)](M) drop induced by a protonophore was fully reversible. In addition, this high [Ca(2+)](M) did not induce PTP opening unless additional activators (phenyl arsine oxide, PAO) were present. PAO induced a rapid, concentration-dependent and irreversible drop in [Ca(2+)](M). In conclusion [Ca(2+)](M) levels of 0.5-1mM can be reached and maintained for prolonged periods (>10 min) in phosphate-containing medium, and massive opening of PTP requires additional pore activators. | lld:pubmed |
pubmed-article:19100620 | pubmed:language | eng | lld:pubmed |
pubmed-article:19100620 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:citationSubset | IM | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
pubmed-article:19100620 | pubmed:status | MEDLINE | lld:pubmed |
pubmed-article:19100620 | pubmed:month | Mar | lld:pubmed |
pubmed-article:19100620 | pubmed:issn | 1532-1991 | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:AlvarezJavier... | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:MonteroMayteM | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:MorenoAlfredo... | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:LobatónCarmen... | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:VayLauraL | lld:pubmed |
pubmed-article:19100620 | pubmed:author | pubmed-author:Hernández-San... | lld:pubmed |
pubmed-article:19100620 | pubmed:issnType | Electronic | lld:pubmed |
pubmed-article:19100620 | pubmed:volume | 45 | lld:pubmed |
pubmed-article:19100620 | pubmed:owner | NLM | lld:pubmed |
pubmed-article:19100620 | pubmed:authorsComplete | Y | lld:pubmed |
pubmed-article:19100620 | pubmed:pagination | 243-50 | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:meshHeading | pubmed-meshheading:19100620... | lld:pubmed |
pubmed-article:19100620 | pubmed:year | 2009 | lld:pubmed |
pubmed-article:19100620 | pubmed:articleTitle | Mitochondrial free [Ca2+] levels and the permeability transition. | lld:pubmed |
pubmed-article:19100620 | pubmed:affiliation | Instituto de Biología y Genética Molecular (IBGM), Departamento de Bioquímica y Biología Molecular y Fisiología, Universidad de Valladolid and Consejo Superior de Investigaciones Científicas (CSIC), Ramón y Cajal, 7, E-47005 Valladolid, Spain. | lld:pubmed |
pubmed-article:19100620 | pubmed:publicationType | Journal Article | lld:pubmed |
pubmed-article:19100620 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |